Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas

被引:24
作者
Bisogna, M
Calvano, JE
Ho, GH
Orlow, I
Cordón-Cardó, C
Borgen, PI
Van Zee, KJ
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Canc Res Lab, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, Breast Canc Res Lab, New York, NY 10021 USA
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0165-4608(00)00367-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The INK4A and INK4B loci are located at 9p21 and have been implicated in the tumorigenesis of various human malignancies. The INK4A gene encodes two cell cycle regulators, p16(INK4A) and ARF, while INK4B encodes p15(INK4B). Previously, we have shown that the p16(INK4) tumor suppressor was not mutated or deleted in primary breast carcinomas. However, primary and metastatic breast carcinomas exhibited a relative hypomethylation of p16(INK4A), which is associated with expression, compared to normal breast tissue. The present study was conducted to determine if inactivation of p15(INK4B) and INK4A exon 1 beta (ARF) are common events in breast carcinoma. Mutational analysis was performed by PCR-SSCP, and mRNA expression was evaluated by RT-PCR. Methylation-specific PCR was used to determine the methylation status of the p15(INK4B) promoter. Our results demonstrate that the p15(INK4B) gene was altered in 3 (21%) of the 14 breast cell lines; one had a silent mutation and two had homozygous deletion of the gene. None of the cell lines showed methylation of p15(INK4B). TWO (14%) cell Lines had homozygous deletion of INK4A exon Ip. All normal and malignant breast tissue samples were wild-type and non-methylated for p15(INK4B) and wild-type for exon 1 beta. Our results show that these structurally and functionally related genes are not invariably affected together, and the most frequently observed alteration at the INK4A and INK4B loci in breast carcinoma appears to be p16INK4A hypomethylation. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 51 条
  • [1] Batova A, 1997, CANCER RES, V57, P832
  • [2] Brenner AJ, 1996, CLIN CANCER RES, V2, P1993
  • [3] RATES OF P16(MTS1) MUTATIONS IN PRIMARY TUMORS WITH 9P LOSS
    CAIRNS, P
    MAO, L
    MERLO, A
    LEE, DJ
    SCHWAB, D
    EBY, Y
    TOKINO, K
    VANDERRIET, P
    BLAUGRUND, JE
    SIDRANSKY, D
    [J]. SCIENCE, 1994, 265 (5170) : 415 - 416
  • [4] Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens
    Calvano, JE
    Rush, EB
    Tan, LK
    Rosen, PP
    Borgen, PI
    VanZee, KJ
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (05) : 416 - 420
  • [5] DURO D, 1995, ONCOGENE, V11, P21
  • [6] Flores JF, 1996, CANCER RES, V56, P5023
  • [7] Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia
    Gardie, B
    Cayuela, JM
    Martini, S
    Sigaux, F
    [J]. BLOOD, 1998, 91 (03) : 1016 - 1020
  • [8] Splicing into senescence: The curious case of p(16) and p19(ARF)
    Haber, DA
    [J]. CELL, 1997, 91 (05) : 555 - 558
  • [9] P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST
    HANNON, GJ
    BEACH, D
    [J]. NATURE, 1994, 371 (6494) : 257 - 261
  • [10] Herman JG, 1996, CANCER RES, V56, P722